Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model

Purpose: Vascular targeted photodynamic therapy (VTP) is a nonsurgical tumor ablation approach used to treat early-stage prostate cancer and may also be effective for upper tract urothelial cancer (UTUC) based on preclinical data. Toward increasing response rates to VTP, we evaluated its efficacy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvim, Ricardo G., Georgala, Petrina, Nogueira, Lucas, Somma, Alexander J., Nagar, Karan, Thomas, Jasmine, Alvim, Laura, Riegel, Amelia, Hughes, Christopher, Chen, Jie, Reis, Augusto B., Lebdai, Souhil, Scherz, Avigdor, Zanganeh, Steven, Gardner, Rui, Kim, Kwanghee, Coleman, Jonathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234268/
https://www.ncbi.nlm.nih.gov/pubmed/34205347
http://dx.doi.org/10.3390/molecules26123744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234268/
https://www.ncbi.nlm.nih.gov/pubmed/34205347
http://dx.doi.org/10.3390/molecules26123744

Ejemplares similares